NEW YORK, Feb. 14 - Human Genome Sciences on Thursday said that bolstered R&D to develop new drugs together with shriveled revenue brought on by the end of the Human Gene Consortium caused net losses to widen in the fourth quarter.
...and receive Daily News bulletins.
Already have an account?Login Now.
The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.
Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.
The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.
In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.